Literature DB >> 27403292

Microvolt T-wave Alternans: Where Are We Now?

Aapo L Aro1, Tuomas V Kenttä2, Heikki V Huikuri2.   

Abstract

Microvolt T-wave alternans (TWA), characterised as beat-to-beat fluctuation of T-wave amplitude and morphology, is an electrophysiological phenomenon associated clinically with impending ventricular arrhythmias and is an important marker of arrhythmia risk. Currently, two main methods for the detection of TWA exist, namely, the spectral method and the time-domain modified moving average method; both are discussed in this review. Microvolt TWA has been associated with cardiovascular mortality and sudden cardiac death in several clinical studies involving >14,000 subjects with reduced as well as preserved left ventricular function. Although TWA appears to be a useful marker of susceptibility for lethal ventricular arrhythmias and cardiovascular death, so far there is no sufficient evidence from randomised clinical trials to support its use in guiding therapy. However, several ongoing trials are expected to provide more information about the clinical use of TWA testing.

Entities:  

Keywords:  Alternans; electrocardiogram; lethal arrhythmias; repolarisation; risk stratification; sudden death

Year:  2016        PMID: 27403292      PMCID: PMC4939287          DOI: 10.15420/aer.2015.28.1

Source DB:  PubMed          Journal:  Arrhythm Electrophysiol Rev        ISSN: 2050-3369


  32 in total

1.  Modified moving average analysis of T-wave alternans to predict ventricular fibrillation with high accuracy.

Authors:  Bruce D Nearing; Richard L Verrier
Journal:  J Appl Physiol (1985)       Date:  2002-02

2.  Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death.

Authors:  Faisal M Merchant; Takanori Ikeda; Roberto F E Pedretti; Jorge A Salerno-Uriarte; Theodore Chow; Paul S Chan; Cheryl Bartone; Stefan H Hohnloser; Richard J Cohen; Antonis A Armoundas
Journal:  Heart Rhythm       Date:  2012-03-08       Impact factor: 6.343

3.  Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.

Authors:  Theodore Chow; Dean J Kereiakes; Cheryl Bartone; Terri Booth; Edward J Schloss; Theodore Waller; Eugene Chung; Santosh Menon; Brahmajee K Nallamothu; Paul S Chan
Journal:  J Am Coll Cardiol       Date:  2006-12-13       Impact factor: 24.094

4.  Comparative analysis of methods for automatic detection and quantification of microvolt T-wave alternans.

Authors:  Laura Burattini; Silvia Bini; Roberto Burattini
Journal:  Med Eng Phys       Date:  2009-09-15       Impact factor: 2.242

5.  Effects of exercise rehabilitation on cardiac electrical instability assessed by T-wave alternans during ambulatory electrocardiogram monitoring in coronary artery disease patients without and with diabetes mellitus.

Authors:  Tuomas Kenttä; Mikko P Tulppo; Bruce D Nearing; Jaana J Karjalainen; Arto J Hautala; Antti M Kiviniemi; Heikki V Huikuri; Richard L Verrier
Journal:  Am J Cardiol       Date:  2014-07-02       Impact factor: 2.778

6.  Evidence regarding clinical use of microvolt T-wave alternans.

Authors:  Stefan H Hohnloser; Takanori Ikeda; Richard J Cohen
Journal:  Heart Rhythm       Date:  2008-10-11       Impact factor: 6.343

7.  The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.

Authors:  Otto Costantini; Stefan H Hohnloser; Malcolm M Kirk; Bruce B Lerman; James H Baker; Barathi Sethuraman; Mary M Dettmer; David S Rosenbaum
Journal:  J Am Coll Cardiol       Date:  2009-02-10       Impact factor: 24.094

Review 8.  Quantitative T-wave alternans analysis for guiding medical therapy: an underexploited opportunity.

Authors:  Richard L Verrier; Marek Malik
Journal:  Trends Cardiovasc Med       Date:  2014-10-17       Impact factor: 6.677

Review 9.  Ability of ambulatory ECG-based T-wave alternans to modify risk assessment of cardiac events: a systematic review.

Authors:  Xiao-Qing Quan; Hong-Lian Zhou; Lei Ruan; Jia-Gao Lv; Ji-Hua Yao; Feng Yao; Kui Huang; Cun-Tai Zhang
Journal:  BMC Cardiovasc Disord       Date:  2014-12-20       Impact factor: 2.298

10.  Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction.

Authors:  Heikki V Huikuri; M J Pekka Raatikainen; Rikke Moerch-Joergensen; Juha Hartikainen; Vesa Virtanen; Jean Boland; Olli Anttonen; Nis Hoest; Lucas V A Boersma; Eivind S Platou; Marc D Messier; Poul-Erik Bloch-Thomsen
Journal:  Eur Heart J       Date:  2009-01-20       Impact factor: 29.983

View more
  3 in total

Review 1.  Current challenges in sudden cardiac death prevention.

Authors:  Domenico Corrado; Alessandro Zorzi; Emilio Vanoli; Edoardo Gronda
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

Review 2.  Precision medicine for cardiovascular disease : Learning lessons from cardiomyopathies.

Authors:  F Sedaghat-Hamedani; H A Katus; B Meder
Journal:  Herz       Date:  2018-03       Impact factor: 1.443

3.  Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation.

Authors:  Markus Zabel; Christian Sticherling; Rik Willems; Andrzej Lubinski; Axel Bauer; Leonard Bergau; Frieder Braunschweig; Josep Brugada; Sandro Brusich; David Conen; Iwona Cygankiewicz; Panagiota Flevari; Milos Taborsky; Jim Hansen; Gerd Hasenfuß; Robert Hatala; Heikki V Huikuri; Svetoslav Iovev; Stefan Kääb; Gabriela Kaliska; Jaroslaw D Kasprzak; Lars Lüthje; Marek Malik; Tomas Novotny; Nikola Pavlović; Georg Schmidt; Tchavdar Shalganov; Rajeeva Sritharan; Simon Schlögl; Janko Szavits Nossan; Vassil Traykov; Anton E Tuinenburg; Vasil Velchev; Marc A Vos; Stefan N Willich; Tim Friede; Jesper Hastrup Svendsen; Béla Merkely
Journal:  ESC Heart Fail       Date:  2018-10-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.